Haloperidol disrupts, clozapine reinstates the circadian rest-activity cycle in a patient with early-onset Alzheimer disease.

Abstract

Measurement of the circadian rest-activity cycle in a patient with early-onset Alzheimer disease for 555 days revealed marked changes in the timing and amount of nocturnal activity. After neuroleptic medication was changed to haloperidol, the rest-activity cycle became completely arrhythmic for two months, concomitant with a marked worsening of cognitive state. Circadian integrity returned together with clinical improvement when the patient was subsequently treated with clozapine. This observation suggests that the known tendency for patients with Alzheimer disease to develop sleep-wake cycle disturbances may be aggravated by a classic neuroleptic; in contrast, the atypical neuroleptic clozapine may consolidate it. Similar observations in schizophrenic patients indicate that this chronobiological finding is drug- and not illness-related.

Extracted Key Phrases

2 Figures and Tables

02040'02'04'06'08'10'12'14'16
Citations per Year

131 Citations

Semantic Scholar estimates that this publication has 131 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{WirzJustice2000HaloperidolDC, title={Haloperidol disrupts, clozapine reinstates the circadian rest-activity cycle in a patient with early-onset Alzheimer disease.}, author={Anna M Wirz-Justice and Esther Werth and Egemen Savaskan and V. Knoblauch and Paola Fontana Gasio and Franz M{\"{u}ller-Spahn}, journal={Alzheimer disease and associated disorders}, year={2000}, volume={14 4}, pages={212-5} }